Nodoryl Dolo (Metamizole Sodium Monohydrate)

Metamizole sodium works by non‑selectively inhibiting cyclooxygenase enzymes, which lowers prostaglandin production. This reduces peripheral sensitisation of pain receptors and lowers the hypothalamic set‑point for temperature, providing both analgesic and antipyretic effects. Central mechanisms also contribute to its spasmolytic activity.

The dose of Nodoryl Dolo is determined by the prescribing clinician based on the patient’s condition, age, weight, and renal or hepatic function. Healthcare professionals adjust the regimen to achieve effective pain or fever control while minimising risk.

Safety of metamizole sodium during pregnancy and lactation has not been established. It is generally avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Nodoryl Dolo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with traditional NSAIDs, metamizole sodium offers analgesic and antipyretic effects with a lower incidence of gastrointestinal irritation but carries a rare risk of severe blood dyscrasias. Unlike opioids, it does not cause respiratory depression or dependence, making it a useful alternative for certain patient groups.

Nodoryl Dolo should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and sources of heat to maintain stability and potency throughout its shelf life.

Nodoryl Dolo is administered orally. The tablet is swallowed whole with a glass of water, preferably after a meal to reduce gastrointestinal discomfort, unless the prescriber advises otherwise.

The most serious risks include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe skin reactions such as Stevens‑Johnson syndrome. Prompt medical attention is required if signs of infection, unexplained fever, or skin blistering develop while using the medication.

Nodoryl Dolo should be avoided in patients with a known hypersensitivity to metamizole or other pyrazolones, those with a history of agranulocytosis or severe leukopenia, and individuals with uncontrolled renal or hepatic impairment unless specifically directed by a physician.